Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration
Abstract
To evaluate the efficacy and safety of ranibizumab 0.5 mg treat-and-extend (T&E) versus monthly regimens in patients with neovascular age-related macular degeneration (nAMD) from the TReat and extEND (TREND) study.A 12-month phase 3b visual acuity (VA) assessor-masked, multicenter, randomized, interventional study.Six hundred fifty patients.Treatment-naïve nAMD patients (age, ≥50 years) were randomized 1:1 to receive either a ranibizumab 0.5 mg...
Paper Details
Title
Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration
Published Date
Jan 1, 2018
Journal
Volume
125
Issue
1
Pages
57 - 65
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History